The Duke Human Vaccine Institute (DHVI) is pleased to announce that Matthew Kelly, MD, MPH, has joined DHVI as an affiliate faculty member.
Dr. Kelly completed his medical education at Harvard Medical School and obtained a Master of Public Health degree from the Harvard School of Public Health in 2007. In 2013, he came to Duke for pediatric infectious diseases training before joining the faculty in 2016. He is an associate professor of pediatrics and associate research professor in global health and molecular genetics and microbiology.
Dr. Kelly’s research career focuses on the impact of the human microbiome on the risk of pathogen colonization and infection in children. He leads the Duke BRAVE Kids Study with faculty member Jillian Hurst, PhD. BRAVE Kids is one of the key biorepository studies established by the Duke University School of Medicine early in the COVID-19 pandemic. To date, this study has collected clinical data and linked biospecimens from more than 700 children and adolescents with acute SARS-CoV-2 infection or exposure or after COVID-19 vaccination. This study aims to understand the biological or immunological factors that account for the differences in SARS-CoV-2 susceptibility and severity that exist by age.
Dr. Kelly received the Young Investigator Award from the Pediatric Infectious Diseases Society (PIDS) in 2022. The award is presented to a physician who has completed pediatric infectious diseases fellowship training in the past seven years and recognizes outstanding contributions to the field. Dr. Kelly also serves as the associate program director for the Pediatric Infectious Diseases Fellowship Program at Duke and is co-director of the Duke Microbiome Center. Learn more about Dr. Kelly here.